Comparison of efficacy and safety of azilsartan and olmesartan in patients with essential hypertensio
Not Applicable
- Conditions
- Hypertension
- Registration Number
- JPRN-UMIN000016249
- Lead Sponsor
- Department of Cardiology, Fukuoka University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1.Severe liver dysfunction. 2.Severe renal dysfunction. 3.Pregnancy or lactation in women. 4.Patients with a history of allergy to any component of the study medications. 5.Patients corresponding to the contraindication of study medications. 6.Ineligible patients according to the judgment by physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depressor effects (office blood pressure)
- Secondary Outcome Measures
Name Time Method 1.Anti-inflammatory effects 2. Changes in biochemical parameters in blood and urine